Brain Tumor Clinical Trials in Washington D.C., District of Columbia

4 studies are recruiting for brain tumor in Washington D.C., District of Columbia right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Vision Improvement Through Behavioral Rehabilitation And Neuroplasticity Training

    The VIBRANT (Vision Improvement through Behavioral Rehabilitation And Neuroplasticity Training) study is a prospective, double-blind, crossover design (within-subject) in participants with homonymous hemianopia-a type of visual field loss resulting from damage to the post-chiasmatic visual pathways…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Georgetown University Medical Center, Washington D.C., District of Columbia
    Run by
    Georgetown University

    See if you can join NCT07105358 on ClinicalTrials.gov

  2. Home-based Vision Rehabilitation Guided by Brain Imaging

    The BRIGHT (Behavioral Rehabilitation Through Image-Guided Home-based Training) study aims to evaluate the effectiveness of image-guided, home-based perceptual training at improving visual performance in individuals with visual field loss. Using a prospective, crossover design, BRIGHT combines visu…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Georgetown University Medical Center, Washington D.C., District of Columbia
    Run by
    Georgetown University

    See if you can join NCT07635329 on ClinicalTrials.gov

  3. Cognitive Outcomes After Brain Substructure-informed Radiation Planning in Pediatric Patients

    The goal of this trial is to determine whether it is possible to minimize radiation dose to parts of the brain that are important for thinking and learning in children who require radiation to treat their tumor, and if this will help reduce neurocognitive (thinking and learning) impairments in thes…

    Stage
    Not phased
    Ages
    1 to 26
    Site
    Sibley Memorial Hospital, Washington D.C., District of Columbia
    Locations
    2 in total
    Run by
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

    See if you can join NCT05658731 on ClinicalTrials.gov

  4. Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

    This is a first in human study of TNG456 alone and in combination with abemaciclib in patients with advanced or metastatic solid tumors known to have an MTAP loss. The first part of the study is an open-label, dose escalation and the second part is an open label dose expansion in specific solid tum…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Sibley Memorial Hospital, Washington D.C., District of Columbia
    Locations
    15 in total
    Run by
    Tango Therapeutics, Inc.

    See if you can join NCT06810544 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.